Company / Current Assets per Share
Summit Therapeutics Inc. Current Assets per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$0.96
FY2025
5-year range
$0.29 / $6.70
FY2021-FY2025
Trend
+59.5%
vs FY2024
Sector context
#194 of 210
Health Care
What the data says
Among 210 Health Care companies, Summit Therapeutics Inc. is in the bottom 8% for current assets per share. Current Assets per Share returned to growth in FY2025 after 2 years of decline, reaching $0.96.
Based on SEC 10-K filings.
0.96 in FY2025 with a 5-year CAGR of -5.9%.
Improved from $0.90 to $0.96 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -47.6%
- 5-Year CAGR
- -5.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 210This company $0.96 Sector average $170.65
▼
-99.4% below sector average
Key checks
Key Insights
- In FY2025, current assets per share increased 59.5% year-over-year.
- Ranks #194 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2022.
- Lowest current assets per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.96 | +59.5% |
| FY2024 | $0.60 | -32.8% |
| FY2023 | $0.90 | -86.6% |
| FY2022 | $6.70 | +2213.9% |
| FY2021 | $0.29 | -77.8% |
| FY2020 | $1.31 | -46.2% |
| FY2019 | $2.43 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026